← All trials
NCT05174585
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 18, 2022
- Primary completion
- Mar 31, 2024
- Completion date
- Mar 31, 2026
- First posted
- Jan 3, 2022
- Last posted
- Sep 19, 2022
- Enrollment
- 62
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jacobio Pharmaceuticals Co., Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.